Renal Nerves Stimulation Study (RNS)
Primary Purpose
Hypertension, Renal Denervation
Status
Completed
Phase
Phase 2
Locations
Netherlands
Study Type
Interventional
Intervention
Electrical mapping, nerve stimulation checked renal denervation procedure
Electrial mapping, nerve stimulation guided renal denervation procedure
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- The patient is willing and able to comply with the protocol and has provided written informed consent.
- Age 18-80 years
- The patient has hypertension and is accepted for renal denervation or combined pulmonary bein isolation and renal denervation
- Glomerular filtration rate >45 mL/min
- No history of renal artery stenosis
Exclusion Criteria:
- Type 1 diabetes mellitus
- Contraindication to chronic anticoagulation therapy or heparin.
- Chronic oxygen use
- Primary pulmonary hypertension
- Woman currently pregnant or breastfeeding or not using reliable contraceptive measures during fertile age.
- Known secondary cause of hypertension
- Mental or physical inability to participate in the study.
- Renal artery stenosis >50% of the arterial lumen, or renal artery lumen ≤3 mm.
- Dual or triple ipsilateral renal artery ostia.
Sites / Locations
- A. Elvan
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
RNS-checked RDN
RNS-guided RDN
Arm Description
20 patients with hypertension will be enrolled undergoing RNS-checked RDN
20 patients with hypertension will be enrolled undergoing RNS-guided RDN
Outcomes
Primary Outcome Measures
arterial blood pressure response
Main study parameter will be the arterial blood pressure response to RNS prior to renal denervation and absence of blood pressure rise in response to pacing in the renal artery after RDN.
Secondary Outcome Measures
blood pressure at 3 months
Blood pressure at 3 months after the intervention
blood pressure at 6 months
Blood pressure at 6 months after the intervention
blood pressure at 12 months
Blood pressure at 12 months after the intervention
change in blood pressure compared to measurement before the intervention
change in blood pressure compared to measurement before the intervention
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02496117
Brief Title
Renal Nerves Stimulation Study
Acronym
RNS
Official Title
Feasibility of Electrical Mapping and Stimulation of Renal Arteries in Patients Undergoing Renal Denervation
Study Type
Interventional
2. Study Status
Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
March 14, 2014 (Actual)
Primary Completion Date
July 4, 2019 (Actual)
Study Completion Date
July 4, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Diagram B.V.
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Study design: Investigator initiated, single centre, feasibility study
Main objectives are twofold:
To investigate the feasibility of RNS in patients with therapy resistant hypertension, which is assessing the functional distribution of renal nerves using 3D imaging and differential pacing modalities.
To investigate the blood pressure responses and cardiac excitable properties to RNS, and subsequently perform a RDN procedure, guided by 3D mapping by two different techniques e.g. RNS-checked RDN and RNS-guided RDN procedures.
Study population: 40 patients (18 - 80 yr old)
Detailed Description
Background: Approximately 10-15% of adults with hypertension are considered to be treatment resistant because their hypertension is uncontrolled despite taking three or more drugs that includes a diuretic. Renal denervation (RDN) is a novel treatment option for therapy resistant hypertension and its rationale originates in denervating the renal sympathetic efferent and afferent coupling with the central autonomic nervous system. By denervating the renal arteries, general sympathetic tone is reduced. Currently, RDN is performed by placing in a spiral pattern 5-6 ablation lesions in each renal artery. 15-30% of the patients do not have any benefit from this procedure. The reason for this is unknown. Experimental data show that renal nerve stimulation (RNS) may serve as a functional endpoint to assess completeness of the RDN procedure. A RNS-guided RDN may prove to be superior to standard RDN (RNS-checked) in blood pressure control.
Main objectives are twofold:
To investigate the feasibility of RNS in patients with therapy resistant hypertension, which is assessing the functional distribution of renal nerves using 3D imaging and differential pacing modalities.
To investigate the blood pressure responses and cardiac excitable properties to RNS, and subsequently perform a RDN procedure, guided by 3D mapping by two different techniques e.g. RNS-checked RDN and RNS-guided RDN procedures.
Secondary objective:
The secondary objective is to compare both techniques (RNS-checked vs. RNS-guided) in terms of efficacy and safety.
Hypotheses:
We hypothesize that identification and localization of the sympathetic nerve bundles using 3D navigation systems and selective pacing manoeuvres will allow a functional approach to denervate the kidneys and improve the success rate of this procedure in patients with hypertension.
We hypothesize that the RNS-guided RDN procedure will show better blood pressure data during follow up, since the completeness has been assessed in contrast to the RNS-checked RDN procedure.
Study design: Investigator initiated, single centre, prospective, feasibility study
Study population: 40 patients (18 - 80 yr old)
20 patients treated with RNS-checked RDN
20 patients treated with RNS-guided RDN
Intervention:
Two different techniques will be used in this trial:
RNS-checked RDN
RNS-guided RDN
Main study endpoints:
Main study parameter will be the arterial blood pressure response to RNS prior to RDN and absence of blood pressure rise in response to pacing in the renal artery after RDN.
Secondary study endpoints:
Blood pressure at 3, 6, 12 months after the intervention, and change in blood pressure compared to measurement before the intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension, Renal Denervation
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
RNS checked RDN
Masking
None (Open Label)
Masking Description
RNS guided RDN
Allocation
Non-Randomized
Enrollment
56 (Actual)
8. Arms, Groups, and Interventions
Arm Title
RNS-checked RDN
Arm Type
Active Comparator
Arm Description
20 patients with hypertension will be enrolled undergoing RNS-checked RDN
Arm Title
RNS-guided RDN
Arm Type
Experimental
Arm Description
20 patients with hypertension will be enrolled undergoing RNS-guided RDN
Intervention Type
Procedure
Intervention Name(s)
Electrical mapping, nerve stimulation checked renal denervation procedure
Other Intervention Name(s)
RNS-checked RDN
Intervention Type
Procedure
Intervention Name(s)
Electrial mapping, nerve stimulation guided renal denervation procedure
Other Intervention Name(s)
RNS-guided RDN
Primary Outcome Measure Information:
Title
arterial blood pressure response
Description
Main study parameter will be the arterial blood pressure response to RNS prior to renal denervation and absence of blood pressure rise in response to pacing in the renal artery after RDN.
Time Frame
during procedure
Secondary Outcome Measure Information:
Title
blood pressure at 3 months
Description
Blood pressure at 3 months after the intervention
Time Frame
3 months after the intervention
Title
blood pressure at 6 months
Description
Blood pressure at 6 months after the intervention
Time Frame
6 months after the intervention
Title
blood pressure at 12 months
Description
Blood pressure at 12 months after the intervention
Time Frame
12 months after the intervention
Title
change in blood pressure compared to measurement before the intervention
Description
change in blood pressure compared to measurement before the intervention
Time Frame
intervention - up to 12 months after the intervention
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
The patient is willing and able to comply with the protocol and has provided written informed consent.
Age 18-80 years
The patient has hypertension and is accepted for renal denervation or combined pulmonary bein isolation and renal denervation
Glomerular filtration rate >45 mL/min
No history of renal artery stenosis
Exclusion Criteria:
Type 1 diabetes mellitus
Contraindication to chronic anticoagulation therapy or heparin.
Chronic oxygen use
Primary pulmonary hypertension
Woman currently pregnant or breastfeeding or not using reliable contraceptive measures during fertile age.
Known secondary cause of hypertension
Mental or physical inability to participate in the study.
Renal artery stenosis >50% of the arterial lumen, or renal artery lumen ≤3 mm.
Dual or triple ipsilateral renal artery ostia.
Facility Information:
Facility Name
A. Elvan
City
Zwolle
State/Province
Overijssel
ZIP/Postal Code
8025AB
Country
Netherlands
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34647513
Citation
Hoogerwaard AF, Adiyaman A, de Jong MR, Smit JJ, Heeg JE, van Hasselt BAAM, Elvan A. Renal nerve stimulation: complete versus incomplete renal sympathetic denervation. Blood Press. 2021 Dec;30(6):376-385. doi: 10.1080/08037051.2021.1982376. Epub 2021 Oct 14.
Results Reference
derived
Learn more about this trial
Renal Nerves Stimulation Study
We'll reach out to this number within 24 hrs